Sztum

Poland

6 total trials 2 recruiting

Filter these 6 trials by phase, condition, sponsor and more.

Open in Search →

OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 5 Cardiovascular Disease
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients with … Recruiting

2023-510369-92-00 4 2025-01-28 Mixed Dyslipidemia
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure Recruiting

2024-518685-27-00 5 2022-03-22 acute/decompensated heart failure
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended recruitment

2022-501608-85-00 5 2023-05-09 Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
Evaluation of safety i efficacy de-escalation antiplatelet strategies in acute coronary syndrome. Ended

2024-518090-34-00 5 2022-02-07 Acute Coronary Syndrom (ACS)
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Und … Ended

2024-515056-20-00 5 2021-07-31 Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoin

Showing 1–6 of 6 trials